Test Price
1,000 AED✅ Home Collection Available
16S rRNA V3-V4 Microbiome Sequencing in UAE | 1000 AED
Executive Summary & Core Metrics
Executive Summary
This advanced molecular assay provides comprehensive bacterial microbiome profiling with 99.9% diagnostic sensitivity via high-throughput sequencing. Offered with ISO 9001:2015 accredited processing, VIP mobile phlebotomy home collection, and telephonic post-test clinical guidance.
- ✓ 99.9% Diagnostic Sensitivity
- ✓ 4-Week Turnaround with Comprehensive Bioinformatics Report
- ✓ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Daily 8 AM – 11 PM)
- ✓ Telephonic Post-Test Clinical Guidance by Specialist Panel
- ✓ Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
Bacterial V3-V4 16S rRNA Amplicon Sequencing is a high-resolution metagenomic assay that taxonomically profiles the entire bacterial community within a clinical specimen by targeting hypervariable regions of the 16S ribosomal RNA gene. This advanced sequencing test is critical for oncologists investigating the gut-tumor axis, medical researchers designing longitudinal microbiome studies, and clinical laboratory scientists validating pre-analytical workflows for biobanking.
| Feature | Our 16S V3-V4 Sequencing Test | Standard Commercial Kit |
|---|---|---|
| Precision & Resolution | Genus-level, dual-indexed with 99.9% base-call accuracy | Genus to family-level, single-index, lower resolution |
| Methodology | Illumina MiSeq PE300 with DADA2 QIIME2 pipeline | Ion Torrent or Oxford Nanopore; variable bioinformatics |
| Turnaround Time | 4 weeks with comprehensive bioinformatics report | 6-8 weeks, limited interpretive support |
Physician Insight & Safety Protocols
“As a medical geneticist, I emphasize that 16S rRNA V3-V4 sequencing data must be interpreted within the full clinical context. No single microbial signature constitutes a diagnosis. Correlate these metagenomic findings with histological, biochemical, and oncological markers to avoid clinical overinterpretation. Your physician remains your primary guide.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA License: 9294403
⚠ Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Recent antibiotic or probiotic use must be disclosed, as it may alter microbial abundance and lead to misinterpretation.
Exclusion Criteria & Emergency Red Flags
- Active systemic infection requiring urgent antibiotic intervention.
- Neutropenic fever or severe immunosuppression — prioritize clinical stabilization, not elective sequencing.
- Known bleeding disorder or severe thrombocytopenia precluding safe whole blood collection.
- Red Flag: If experiencing high-grade fever, chills, or signs of sepsis, proceed directly to the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What exactly does the 16S rRNA V3-V4 sequencing test measure in a clinical sample?
This test sequences and identifies all bacterial species present in your DNA sample by targeting the species-specific V3-V4 hypervariable region of the 16S ribosomal RNA gene locus. It provides a taxonomic profile of the bacterial microbiome.
2. How should an oncology patient prepare for this microbiome sequencing test?
For whole blood collection, avoid antibiotics or probiotics for at least 4 weeks prior to ensure an accurate native microbial profile. Follow your physician's instructions for any medication adjustments.
3. Can this test diagnose cancer or other specific diseases directly?
No, this sequencing profiles microbial communities for research and adjunctive clinical correlation only. It does not provide a direct oncological diagnosis independently. Results must be interpreted by a qualified physician.
UAE Regulatory & Data Privacy Adherence
This test is performed under the regulatory oversight of the Dubai Health Authority (DHA) and complies with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability
All patient data is encrypted and handled in accordance with UAE data protection standards.
Clinical & Logistical Metadata
| Test Name | 16S rRNA V3-V4 Microbiome Sequencing |
| Price (AED) | 1000 |
| Turnaround Time | 4 weeks with comprehensive bioinformatics report |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Illumina MiSeq PE300 with DADA2 QIIME2 pipeline |
| ICD-10-CM Code | Z13.89 |
| LOINC Code | 82093-2 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Operated by DNA Labs UAE. |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians